RECENT NEWS

Olusegun Olayemi wins Elisabeth Pletscher Award

The International Federation of Biomedical Laboratory Science (IFBLS) has awarded Olusegun Olayemi the Elisabeth Pletscher Award. This award is given to an outstanding IFBLS Associate member for their continuous support of biomedical laboratory science through continuing education and other activities, and to promote the objectives of IFBLS.

News

/ Aug 19, 2016

Life sciences participation at Harvest Festival

In July, life sciences staff at Coventry University were invited to participate in a Science and Nature Trail at the Harvest Festival held at Jimmy’s Farm in Ipswich. Jimmy Doherty, an ex-Coventry University graduate, is well known from the BBC programme Jimmy’s Farm and through his partnership with Jamie Oliver on Channel 4.

News

/ Aug 19, 2016

Taking the fight to antimicrobial resistance

Scientists from around the world attending the EuroScience Open Forum (ESOF) conference in Manchester recently heard that 2016 marks the year a ‘long overdue’ scientific fight back against the threat of antibiotic resistance finally gets underway.

News

/ Aug 12, 2016

Designer protein aids study of Alzheimer’s disease

A new protein which will help scientists to understand why nerve cells die in people with Alzheimer’s disease has been designed in a University of Sussex laboratory.

News

/ Aug 12, 2016

Citylabs: a strategic partnership in the heart of Manchester

Manchester Science Partnerships (MSP) is to invest £60 million in a major expansion of Citylabs, its biomedical centre of excellence, in partnership with Central Manchester University Hospitals NHS Foundation Trust (CMFT). In a major vote of confidence for the Manchester city region, the development will create Citylabs 2.0 and Citylabs 3.0 on the CMFT campus, in the heart of Manchester’s Innovation District, Corridor Manchester.

News

/ Aug 12, 2016

Leukaemia study takes aim at therapy-resistant proteins

Assessing a patient's levels of P-glycoprotein soon after they start receiving Glivec therapy will help to predict their long-term response to the leukaemia drug, according to new research from South Australia (Eadie LN, Dang P, Saunders VA et al. The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment. Leukemia 2016 Jun 24 [Epub ahead of print]).

News

/ Aug 12, 2016

Less-concentrated hydrogen peroxide fails to kill MRSA

Methicillin-resistant Staphylococcus aureus (MRSA) is not eradicated with low-concentration hydrogen peroxide airborne treatment, according to the latest research published recently. A comparative study conducted by an independent laboratory, published in Letters in Applied Microbiology (Murdoch LE, Bailey L, Banham E, Watson F, Adams NM, Chewins J. Evaluating different concentrations of hydrogen peroxide in an automated room disinfection system. Lett Appl Microbiol 2016 Jun 21. doi: 10.1111/lam.12607 [Epub ahead of print]), tested the efficacy of 5%, 10% and 35% weight by weight (w/w) hydrogen peroxide solutions when used with an automated room disinfection system.

News

/ Jul 28, 2016

Primary screening for human papillomavirus

The introduction of human papillomavirus (HPV) primary screening in England was announced recently. DNA-based HPV testing has been at the heart of research over the past 10 years, through the landmark ATHENA study, which has demonstrated the long‐term safety of using HPV DNA as a predictor of cervical cancer risk.

News

/ Jul 28, 2016

John James awarded Honorary Doctorate at Middlesex University

John Lawrence James, whose biomedical science expertise culminated in worldwide responsibility for quality and competence in medical laboratories, has been awarded an Honorary Doctorate at a recent Middlesex University graduation ceremony.

News

/ Jul 28, 2016

Longitude Prize introduces Superbugs app

Superbugs is an app-based game produced by the Longitude Prize, aimed at those in the 11–16 age group. Players fight superbugs using existing and new antibiotics, and try to survive against the most virulent strains of bacterial infections.

News

/ Jul 28, 2016

Predicting response to TB treatment

It is now possible to predict how well tuberculosis (TB) responds to drug treatment, according to a new study at Brighton and Sussex Medical School. Dr Simon Waddell, working with a team of researchers from the UK, South Africa and Finland, has discovered bacterial biomarkers that predict early treatment success. This may allow patients to finish drug therapy early, reducing the difficult and debilitating side-effects of the drugs and cutting treatment costs.

News

/ Jun 20, 2016

New potential in islet transplant therapy

The Cell and Gene Therapy Catapult (CGT) and the University of Aberdeen have launched Islexa, a new company developing a novel technology to produce laboratory-grown islets, which are responsible for insulin production. The technology could bring the option of an islet transplant to thousands more patients with type I diabetes mellitus (T1DM).

News

/ Jun 20, 2016

Enterprise and integration in information management

The Integrated Laboratory Services for Barnsley Hospital NHS Foundation Trust and The Rotherham NHS Foundation Trust will replace its current laboratory information management system (LIMS) with the CliniSys WinPath Enterprise system.

News

/ Jun 20, 2016

Disposal of end-of-life equipment

Medisort is a healthcare waste management provider, working with healthcare professionals in hospitals, GP practices, dentists, tattooists and veterinary surgeons. The company treats infectious or potentially infectious waste in its own facilities, helping customers comply with the law.

News

/ May 24, 2016

Flexible water purification in York

Suez Treatment Solutions has provided two new water purification units to the University of York’s Biology Department. The two machines are a Select Fusion and Select Neptune. The Fusion is for analytical and life science applications that need small volumes of ultrapure water (typically up to 50 L per day), while the Neptune is for higher volumes of up to 2 L per minute.

News

/ May 24, 2016

Relationship management in pathology

CliniSys has announced a new partnership with hc1.com, through which it will deliver a ‘powered by hc1’ pathology customer relationship management (CRM) and live analytics solution, offering an innovative platform that enables laboratories to deliver the highest level of service.

News

/ May 24, 2016

Point-of-care haematology and sports and exercise medicine

Horiba UK has recently installed its first Yumizen H500 at the National Centre for Sports and Exercise Medicine, East Midlands, (NCSEM-EM), based at Loughborough University. The Yumizen H500 is a small, compact analyser that provides a full blood count plus five-population WBC differential on very small sample volumes using only three reagents.

News

/ May 24, 2016

Improved molecular diagnostics in Milan

A case study describing the experiences of Niguarda Hospital, Milan, in assessing the new DxN VERIS Molecular Diagnostics System is now available from Beckman Coulter. The case study describes the workflow improvements and reduced turnaround times that the hospital’s molecular biology laboratory has achieved for viral load measurements using the DxN VERIS system.

News

/ May 24, 2016

Belfast laboratories commended at employer awards

The laboratories of the Belfast Health and Social Care Trust (BHSCT) received a highly commended certificate at the Ulster University Placement Employer of the Year Awards ceremony, held last month. The laboratories in the trust facilitate a 52-week placement programme each year for up to eight Ulster University students undertaking the degree programme in biomedical sciences.

News

/ May 24, 2016

Grants available for practical microbiology education

The British Society for Microbial Technology (BSMT) is offering a limited number of grants of up to £1000 to assist with the practical side of laboratory-orientated education. Whether to purchase kits or other consumables and reagents, to complete a research project or to undertake a service evaluation within a microbiology laboratory setting, the BSMT can help.

News

/ May 24, 2016

Featured Supplier

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $20 billion and more than 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics...

Learn more »

Latest Issue

Pathology In Practice

Feb 2019

Early disease detection: a collaborative approach

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.